NCT07031830
APA (Adapted Physical Activity) for Patients With Advanced Melanoma
Recruiting · Not specified · University Hospital, Rouen · registry updated 2025-06-22
Inclusion and exclusion lines below are quoted from ClinicalTrials.gov. No match score is shown, because a score needs a person's age, biomarkers, and treatment dates. Confirm the record with the study team.
APA (adapted physical activity) for patients with advanced melanoma APA (adapted physical activity) for patients with advanced melanoma undergoing treatment: evaluation of a personalized program at the hospital Melanoma is a malignant tumor developed from melanocytes. It accounts for approximately 4% of all incident cancers and 1.2% of cancer deaths, regardless of sex. Since 2011, the advent of new therapies (targeted therapies and immunotherapies) has revolutionized the management of advanced-stage melanoma (unresectable stage III or stage IV). These treatments have led to a significant improvement in the prognosis of metastatic melanoma, with a 5-year overall survival rate of 34% for targeted therapies, 44% for monotherapy with immunotherapy, and 52% for the combination of nivolumab + ipilimumab. Due to the improvement in survival rates, advanced melanoma has become a chronic disease affecting all ages. It is therefore essential to maintain the quality of life for these patients.
Inclusion
- Male or female patient aged 18 or older
- Advanced melanoma treated adjuvantly or curatively with immunotherapy or targeted therapy
- Patient who has read and understood the information letter and does not object to participating in the study
- Member of or beneficiary of a social security scheme
- Patients who have agreed to participate in the adapted sports module
Exclusion
- Minor patient
- Melanoma not requiring systemic treatment
- Condition making 6-month follow-up impossible
- Protected incapacitated persons (judicial protection, guardianship, curatorship, deprivation of liberty)